Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brefel-Courbon

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Drugs & Aging|August 3, 2001
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and managementJ M Senard, C Brefel-Courbon, O Rascol, et al.
European Journal of Clinical Pharmacology|July 29, 1999
Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's diseaseC Thalamas, A Taylor, C Brefel-Courbon, et al.
British Journal of Pharmacology|August 24, 1999
Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanismsE Lazartigues, C Brefel-Courbon, M A Tran, et al.
Revue Neurologique|February 17, 2007
[Levodopa modifies pain thresholds in Parkinson's disease patients]T Slaoui, A Mas-Gerdelat, F Ory-Magne, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|February 24, 2001
Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variabilityC Brefel-Courbon, C Thalamas, O Rascol, et al.
Revue Neurologique|October 13, 2023
The effectiveness and safety of non-pharmacological intervention for pain management in Parkinson's disease: A systematic reviewM Huissoud, M Boussac, K Joineau, et al.
Fundamental & Clinical Pharmacology|November 18, 1998
Endogenous central cholinergic systems and baroreflex modulation in the conscious dogE Lazartigues, M A Tran, C Brefel-Courbon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's diseaseJ L Montastruc, K Desboeuf, M Lapeyre-Mestre, et al.
Neurology|April 21, 2012
Identification of VPS35 mutations replicated in French families with Parkinson diseaseS Lesage, C Condroyer, S Klebe, et al.
European Journal of Pharmacology|July 4, 1998
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin releaseC Allal, E Lazartigues, M A Tran, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Drugs & Aging|August 3, 2001
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and managementJ M Senard, C Brefel-Courbon, O Rascol, et al.
European Journal of Clinical Pharmacology|July 29, 1999
Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's diseaseC Thalamas, A Taylor, C Brefel-Courbon, et al.
British Journal of Pharmacology|August 24, 1999
Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanismsE Lazartigues, C Brefel-Courbon, M A Tran, et al.
Revue Neurologique|February 17, 2007
[Levodopa modifies pain thresholds in Parkinson's disease patients]T Slaoui, A Mas-Gerdelat, F Ory-Magne, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|February 24, 2001
Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variabilityC Brefel-Courbon, C Thalamas, O Rascol, et al.
Revue Neurologique|October 13, 2023
The effectiveness and safety of non-pharmacological intervention for pain management in Parkinson's disease: A systematic reviewM Huissoud, M Boussac, K Joineau, et al.
Fundamental & Clinical Pharmacology|November 18, 1998
Endogenous central cholinergic systems and baroreflex modulation in the conscious dogE Lazartigues, M A Tran, C Brefel-Courbon, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's diseaseJ L Montastruc, K Desboeuf, M Lapeyre-Mestre, et al.
Neurology|April 21, 2012
Identification of VPS35 mutations replicated in French families with Parkinson diseaseS Lesage, C Condroyer, S Klebe, et al.
European Journal of Pharmacology|July 4, 1998
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin releaseC Allal, E Lazartigues, M A Tran, et al.
Pageof 5